Framing the numerical findings of Cochrane plain language summaries: two randomized controlled trials.

Evidence summaries Health numeracy Information translation Plain language summaries

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
06 05 2020
Historique:
received: 28 10 2019
accepted: 23 04 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 25 6 2021
Statut: epublish

Résumé

Cochrane systematic review Plain language Summaries (CSR PLSs should serve as a tool for the evidence translation to non-medical population. However, the evidence of optimal type of numerical presentation in CSR PLSs is still scarce. The aim of this study was to investigate readers' comprehension and preferences for different presentation of findings, including framing and numerical data, in Cochrane systematic review Plain Language Summaries (CSR PLSs). We conducted a parallel randomized trial and a crossover randomized trial at the School of Medicine and family practice offices in Split, Croatia. The participants were students and consumers. We assessed possible differences in comprehension, measured by four questions on PLS content, of CSR PLSs depending on the positive or negative framing of results (n = 91) (Trial 1) or using percentages or frequencies for the presentation of results (n = 245) (Trial 2). The outcome measures were comprehension of PLS content, perceived effectiveness of the treatment and readiness to use the treatment (all on 1-10 scales). In Trial 1 we found no difference in readers' perception of the effectiveness of the described treatment, desire that the treatment be offered by their family doctor, readiness to use the treatment, or comprehension when CSR PLS results were presented positively or negatively. In Trial 2 we found no difference in CSR PLS comprehension when results were presented as natural frequencies or percentages (BF Numerical presentation and framing direction of results appear to have no significant impact on understanding of messages in CSR PLSs. The trials were registered in ClinicalTrials.gov. Protocol registration numbers: Trial 1: NCT03442387; Trial 2: NCT03554252.

Sections du résumé

BACKGROUND
Cochrane systematic review Plain language Summaries (CSR PLSs should serve as a tool for the evidence translation to non-medical population. However, the evidence of optimal type of numerical presentation in CSR PLSs is still scarce. The aim of this study was to investigate readers' comprehension and preferences for different presentation of findings, including framing and numerical data, in Cochrane systematic review Plain Language Summaries (CSR PLSs).
METHODS
We conducted a parallel randomized trial and a crossover randomized trial at the School of Medicine and family practice offices in Split, Croatia. The participants were students and consumers. We assessed possible differences in comprehension, measured by four questions on PLS content, of CSR PLSs depending on the positive or negative framing of results (n = 91) (Trial 1) or using percentages or frequencies for the presentation of results (n = 245) (Trial 2). The outcome measures were comprehension of PLS content, perceived effectiveness of the treatment and readiness to use the treatment (all on 1-10 scales).
RESULTS
In Trial 1 we found no difference in readers' perception of the effectiveness of the described treatment, desire that the treatment be offered by their family doctor, readiness to use the treatment, or comprehension when CSR PLS results were presented positively or negatively. In Trial 2 we found no difference in CSR PLS comprehension when results were presented as natural frequencies or percentages (BF
CONCLUSIONS
Numerical presentation and framing direction of results appear to have no significant impact on understanding of messages in CSR PLSs.
TRIAL REGISTRATION
The trials were registered in ClinicalTrials.gov. Protocol registration numbers: Trial 1: NCT03442387; Trial 2: NCT03554252.

Identifiants

pubmed: 32375659
doi: 10.1186/s12874-020-00990-4
pii: 10.1186/s12874-020-00990-4
pmc: PMC7201737
doi:

Banques de données

ClinicalTrials.gov
['NCT03554252', 'NCT03442387']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101

Subventions

Organisme : Hrvatska Zaklada za Znanost
ID : IP-2014-09-7672
Pays : International

Références

Health Commun. 2019 Jul;34(8):859-871
pubmed: 29474125
Iran Red Crescent Med J. 2013 Feb;15(2):161-5
pubmed: 23682330
BMC Med Res Methodol. 2016 May 23;16:61
pubmed: 27216616
Patient Educ Couns. 2016 Mar;99(3):310-325
pubmed: 26519238
J Clin Epidemiol. 2018 May;97:86-94
pubmed: 29269021
Cochrane Database Syst Rev. 2014 Aug 26;(8):CD011275
pubmed: 25157702
J Gen Intern Med. 2011 Dec;26(12):1411-7
pubmed: 21792695
Cochrane Database Syst Rev. 2015 Jul 31;(7):CD011474
pubmed: 26230487
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922
pubmed: 22258993
J Evid Based Med. 2015 Sep 15;9(1):4-7
pubmed: 26372327
Cochrane Database Syst Rev. 2016 Sep 22;9:CD012190
pubmed: 27654948
Patient Educ Couns. 2016 Jan;99(1):36-43
pubmed: 26277826
Ann Intern Med. 2011 Jul 19;155(2):97-107
pubmed: 21768583
Psychol Bull. 2009 Nov;135(6):943-73
pubmed: 19883143
Trials. 2016 Jan 12;17:19
pubmed: 26758509
Health Commun. 2019 Jul 22;:1-12
pubmed: 31328567
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD006777
pubmed: 22161408
Health Commun. 2014;29(9):843-53
pubmed: 24266723
J Health Commun. 2014;19 Suppl 2:29-43
pubmed: 25315582
Croat Med J. 2017 Aug 31;58(4):300-309
pubmed: 28857523
Cochrane Database Syst Rev. 2015 May 27;(5):CD009923
pubmed: 26017279

Auteurs

Ivan Buljan (I)

Department of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia. ibuljan@mefst.hr.
Cochrane Croatia, University of Split School of Medicine, Split, Croatia. ibuljan@mefst.hr.

Ružica Tokalić (R)

Department of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Cochrane Croatia, University of Split School of Medicine, Split, Croatia.

Marija Roguljić (M)

Department of Oral Diseases and Periodontology, University of Split School of Medicine, Split, Croatia.

Irena Zakarija-Grković (I)

Department of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Cochrane Croatia, University of Split School of Medicine, Split, Croatia.

Davorka Vrdoljak (D)

Department of Family Medicine, University of Split School of Medicine, Split, Croatia.

Petra Milić (P)

University of Split School of Medicine, Split, Croatia.

Livia Puljak (L)

Center for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Zagreb, Croatia.

Ana Marušić (A)

Department of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Cochrane Croatia, University of Split School of Medicine, Split, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH